Cargando…
Relationship of driver oncogenes to long term pemetrexed response in non-small cell lung cancer
BACKGROUND: Pemetrexed is approved in the treatment of advanced stage non-squamous non-small-cell lung cancer (NSCLC). The length of response is variable, and we thus sought to identify which clinicopathologic characteristics are associated with long term disease control with pemetrexed. METHODS: Pa...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490141/ https://www.ncbi.nlm.nih.gov/pubmed/25665893 http://dx.doi.org/10.1016/j.cllc.2014.12.009 |